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Background: Bovine respiratory syncytial virus (BRSV) is one of the major pathogens involved in the bovine
respiratory disease (BRD) complex. The seroprevalence to BRSV in Norwegian cattle herds is high, but its role in
epidemics of respiratory disease is unclear. The aims of the study were to investigate the etiological role of BRSV
and other respiratory viruses in epidemics of BRD and to perform phylogenetic analysis of Norwegian BRSV strains.
Results: BRSV infection was detected either serologically and/or virologically in 18 (86%) of 21 outbreaks and in
most cases as a single viral agent. When serology indicated that bovine coronavirus and/or bovine parainfluenza
virus 3 were present, the number of BRSV positive animals in the herd was always higher, supporting the view of
BRSV as the main pathogen. Sequencing of the G gene of BRSV positive samples showed that the current
circulating Norwegian BRSVs belong to genetic subgroup II, along with other North European isolates. One isolate
from an outbreak in Norway in 1976 was also investigated. This strain formed a separate branch in subgroup II,
clearly different from the current Scandinavian sequences. The currently circulating BRSV could be divided into two
different strains that were present in the same geographical area at the same time. The sequence variations
between the two strains were in an antigenic important part of the G protein.
Conclusion: The results demonstrated that BRSV is the most important etiological agent of epidemics of BRD in
Norway and that it often acts as the only viral agent. The phylogenetic analysis of the Norwegian strains of BRSV
and several previously published isolates supported the theory of geographical and temporal clustering of BRSV.
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Bovine respiratory disease (BRD) is of significant import-
ance for production and animal welfare in the cattle in-
dustry [1-3]. The bovine respiratory syncytial virus
(BRSV) is one of the major contributors to BRD, indu-
cing clinical signs that may vary from none to fatal [4,5].
The seroprevalence is generally found to be high, with
up to 100% seropositive herds in some areas [6-10]. A
recent nationwide serological study indicated that 54%
of the dairy herds in Norway had BRSV present in the
herd the previous year [11]. BRSV infections can appear
as epidemics with outbreaks affecting many animals in
several herds within the same area or as part of* Correspondence: thea.klem@nmbu.no
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stated.protracted respiratory disease problems in single herds,
i.e. enzootic pneumonia. BRD epidemics occur fre-
quently in Norway during the winter, when the animals
are housed indoors. BRSV was isolated in Norway
already in 1976 during a severe epizootic outbreak which
spread throughout most of the country [12]. Only spor-
adic outbreaks were reported in the following years, but
in 1995 another severe epidemic was reported [13]. The
Norwegian cattle population is currently free from bo-
vine herpes virus type 1 (BHV 1) [14] and bovine virus
diarrhoea virus (BVDV) [15], and Mycoplasma bovis has
never been detected [16].
BRSV belongs to the genus Pneumovirus in the family
Paramyxoviridae. The gene coding for the surface cell
attachment glycoprotein (G protein) has the highest re-
ported mutation rate and is commonly used as the target
for investigations involving molecular epidemiology andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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Table 1 Overview over analysed material from animals in
herds with acute outbreak of respiratory disease
Sample
category
No. of herds
sampled
No. of animals
analysed
Method of
detection
Paired serum 20 94 ELISA
Single serum 1 10 ELISA
Nasal swabs* 21 86 RTqPCR
BAL* 9 37 RTqPCR
TA* 7 19 RTqPCR
The ELISA detected antibodies against BRSV, BCoV and BPIV3, and the RTqPCR
detected RNA of BRSV.
BAL broncheoalveolar lavage, TA tracheal aspirate. Nasal swabs* and TA* or
BAL* from herds that were negative based on serology were not analysed.
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main targets associated with induction of protective im-
munity [18] and the high variability of the protein could
indicate that the acquired immune response constitutes
an important selective pressure. Previous studies have
shown that quasispecies of BRSV are present in vivo.
The role of this quasispecies distribution is uncertain,
but it could represent a reservoir for virus adaptation
during infection [19,20]. Antigen variation of the G pro-
tein as an escape mechanism in relation to the use of
vaccines have been discussed [4,21]. Vaccines against
BRSV are rarely used in Norway.
There is only one serotype of BRSV [22]. Four anti-
genic subtypes called A, B, AB and untyped have been
defined based on MAbs directed against the G protein
[23,24]. Nucleotide sequence variation of the G gene di-
vides BRSV into six different genetic subgroups, while
similar analysis of the N and F genes only result in five
subgroups, illustrating the higher rate of evolution of the
G gene. Isolates of BRSV from Northern Europe, includ-
ing Denmark and Sweden, cluster in subgroup II [17].
The aims of the study were to investigate the etio-
logical role of BRSV and other respiratory viruses in epi-
demics of BRD and to perform phylogenetic analysis of
Norwegian BRSV strains.
Methods
Selection of herds
Included in the study were 21 cattle herds with acute
outbreak of BRD of which five were fattening and 16
were dairy herds. The herds were located in the South-
Eastern and Western part of Norway, and samples were
collected between March 2009 and June 2011.
A network of veterinary practitioners was established
to facilitate early warning of outbreaks. The inclusion
criteria for herds were: 1) Acute outbreak of respiratory
disease affecting a large proportion of the animals in the
herd. 2) The outbreak was assessed to be in an early
phase.
Selection of individual animals
The inclusion criteria for animals were to be in an early
stage of infection, i.e. without clinical signs but housed
in a pen with diseased animals or having mild coughing
and fever. On average five animals was included from
each herd, but due to practical limitations, i.e. available
animals, the number of animals ranged from two to
seven. A total of 104 animals were sampled. In one herd
(#17), an additional 93 animals were included. These
had coincidently been sampled in the period from six
days before, until the day of the outbreak in connection
with another research project, and they did not show
clinical signs of respiratory disease at the time of
sampling.Sampling and data collection
From 17 herds sampling was conducted by the same vet-
erinary surgeon and samples were transported to the la-
boratory the same day. Both serum samples and nasal
swabs from 86 of the animals in these herds were col-
lected. In 16 of these herds transtracheal aspirate (TA)
or broncheoalveolar lavage (BAL) were collected from
65 of the same animals. In the last one, only serum and
nasal swabs were collected because of difficulties in col-
lecting BAL samples due to the large size of the animals.
Due to practical reasons, the sampling of TA was per-
formed instead of BAL in the first seven herds included
in the study. From the 93 animals sampled before the
outbreak in herd #17, only nasal swabs were collected.
From additional four herds sampling was conducted by
veterinary practitioners and was limited to nasal swabs
and sera. These samples were sent by mail to the labora-
tory and were received the following day.
Paired serum samples were collected from 94 animals
of the 21 herds. The samples were collected with three
to five weeks interval. Ten animals from five herds were
not available for the second sampling (dead/slaughtered
or sold). The TA or BAL samples were collected at the
same day as the collection of the nasal swabs and the
first serum sample. Table 1 shows an overview of ani-
mals tested and the laboratory methods used.
The BAL was obtained by instilling 100 ml Hanks bal-
anced salt solution (HBSS) via the nostrils into the
bronchia through a silicone rubber tube. The diameter
of the tube was 10 mm with a 2.5 mm inner channel.
Approximately 30 ml was collected. The TA was per-
formed by instilling 40 ml HBSS via a polythene tube.
The tube had a diameter of 1.57 mm and an inner chan-
nel of 1.14 mm and was passed through an incision in
the skin and trachea through a catheter with a diameter
of 2.7 mm placed in the trachea. Prior to the incision in
the skin, five ml of local anaesthetics containing 100 mg
of lidocaine and 180 μg adrenaline was administered
subcutaneously around the incision site. Sedation of the
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by an intramuscular injection of 0.1 mg/kg of xylazine.
The study was based on natural outbreaks of BRD.
The samples taken and procedures performed for diag-
nostic purposes were according to standard veterinary
practice. Therefore it was concluded that formal ethics
approval was not necessary. This is in line with the
Norwegian Regulation on Animal Experimentation,
where it is exemption for treatment and surgery con-
ducted as part of a clinical veterinary procedure, when a
recognized method is used.
Antibody detection
Sera were stored at −20°C until they were analysed. An
indirect ELISA that detects antibodies to BRSV, bovine
parainfluenza virus 3 (BPIV3) and bovine coronavirus
(BCoV) (SVANOVIR® BRSV-Ab, PIV3-Ab and BCV-Ab,
Svanova Biotech AB, Uppsala, Sweden) was used follow-
ing the manufacturer’s instructions. In brief, the reading
of the optical density (OD) at 450 nm was corrected by
the subtraction of OD for the negative control antigen,
and percent positivity (PP) was calculated as (corrected
OD/positive control corrected OD) × 100. The sensitivity
and specificity of the tests reported by the manufacturer
was 94.6% and 100% for BRSV, 95.4% and 98.5% for
BPIV3 and 100% and 84.6% for BCoV respectively. The
animals were regarded as acutely infected with BRSV,
BCoV and/or BPIV3 if the first sample was negative and
the second sample was positive, or if the PP increased at
least 70%.
The difference in mean herd size of the herds with
only one viral agent detected by serology versus those
with several viral agents was analysed with a One-way
analysis of variance.
Real time PCR (RTqPCR)
Animals from herds found to have an acute BRSV infec-
tion as based on the serologic results, or with ambiguous
results, were analysed by RTqPCR. Nasal swabs and la-
vages were analysed (Table 1). From 36 animals both
nasal swabs and BAL were analysed.
The nasal swabs and 0.3 ml of the lavages were put dir-
ectly in 0.5 and 1.5 ml of RNAlater® (Life Technologies™,
Carlsbad CA) respectively, and stored at 4°C for 24 h and
then at −80°C until analysis. Samples were thawed and cen-
trifuged at 4000 × g for 7.5 min. The supernatant was re-
moved, and the remaining pellet was dissolved in 300 μl of
RNAse free H2O. RNA was extracted from 150 μl of this
dissolution using QIAamp® Viral RNA (Qiagen) according
to the manufacturer’s instructions, resulting in RNA diluted
in 60 μl buffer. Detection of BRSV in nasal swabs and BAL
samples was performed by using five μl of the RNA solu-
tion in a BRSV specific RTqPCR (TaqVet™, Laboratoire
Service International, Lissieu, France) amplifying fragmentsof the BRSV N gene, in Stratagene Mx3005p real-time ther-
mal cycler (Agilent Technologies, Santa Clara, CA). All
samples were tested in duplicates. Negative controls were
included in the RNA extraction and the RTqPCR. A sample
was regarded positive for BRSV if the cycle threshold (Ct)
was below 45 for both parallels following the manufac-
turer’s recommendation.
Sequencing of G gene
A nested PCR was used to amplify a 541 nucleotide
fragment of the BRSV G gene using primer sets as
previously described [17]. In brief, RNA was incu-
bated at 65°C for five min and chilled on ice, and
RT reaction was run using Superscript III RT (Invi-
trogen) and the G2.5 primer and incubated at 55°C
for 60 min. For the nested PCR the primer sets
G2.5, F2.7 and VG1, VG4, respectively were used
[17]. The cycling conditions were 40 cycles with
95°C for 20 s, 55°C for 20 s and 72°C for 30 s using
the PfuUltra II Fusion HS (Agilent Technologies)
DNA polymerase. The cycles were preceded by a de-
naturation step at 95°C for one min and completed
by an elongation step at 72°C for three min. The
PCR products were separated by agarose gel electro-
phoresis, purified using the QIAquick PCR Purifica-
tion protocol (Qiagen), and nucleotide sequences
were obtained (Sanger sequencing) from a total of
24 samples (GATC Biotech AG, Germany). Primer
sequences were removed prior to analysis. The
sequences of animals from 10 herds and from a
Norwegian BRSV isolate from 1976 (A1/N/76),
which also originated from an epidemic in the
South-Eastern area of Norway, were included. The
nucleotide sequences used in this study have been
submitted to GenBank and assigned the accession
numbers KF501149 – KF501172.
Phylogenetic and statistical analysis
Contigs of the sequences were made using Vector NTI
software package (Invitrogen), and nucleotide sequence
alignments were performed using Mega 5 [25] with the
Maximum Likelihood method based on the JTT matrix-
based model. The pairwise nucleotide distances were es-
timated using the Tamura-Nei model ignoring positions
with gaps. Initial trees for the heuristic search were ob-
tained automatically; when the number of common sites
was < 100 or less than one-fourth of the total number of
sites, the maximum parsimony method was used. Other-
wise BIONJ method with MCL distance matrix was
used. Bootstrap values of 1000 replicates were used to
assess the nodal support.
JMP 9 (SAS Institute Inc., Cary North Carolina, USA)
was used for performance of the One-way analysis of
variance.
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Serology
The ELISA results are presented in Table 2. Of the indi-
viduals animals 64 out of 94 (68%) were found to have
an acute BRSV infection based on antibody response.
Fifteen out of the 94 (16%) were found to be positive for
BCoV, and for BPIV3 the number was 11 out of 94
(12%). On herd level, 16 (80%), seven (35%) and three
(15%) were found to have animals with antibody re-
sponse to BRSV, BCoV and BPIV3, respectively. Anti-
body response only against BRSV was detected in 11
herds, only against BCoV in two herds and only against
BPIV3 in one. Antibody responses against both BRSV
and BCoV were detected in two herds, while in three
herds antibody response against all three viruses were
found. In one of the two remaining herds, the animals
were seronegative or had a decrease in antibody titre for
all three viruses. In the last herd, antibodies against all
three viruses were detected, but only single serum sam-
ples were available. Concequently, the serological results
of this herd were inconclusive and excluded from the
calculations based on the serological results.Table 2 Serological results from animals in herds with outbre
Herd size Herd no. Mean age of sampled animals BRSV infecti
No. pos/samp
13 20 3.9 yrs 5/5
20 1 2.3 yrs 1/2
24 21 3.5 yrs 3/3
27 16 3.0 mo 4/5
51 6 2.2 mo 1/5
55 4 1.2 yrs 7/7
71 7 1.2 yrs 6/7
74 3 1.7 mo 0/4
83 11 7.3 mo 3/5
95 14 3.8 mo 1/3
136 13 4.8 mo 3/3
171 8 10.5 mo 6/6
193 18 7.1 mo 4/5
210 10 5.5 mo 5/5
210 15 3.7 mo 5/5
220 19 2.7 mo 0/5
250 12 5.7 mo 0/3
256 5 1.4 mo 0/5
265 17 4.7 mo 5/6
300 9 1.6 yrs 5/5
Total 64/94
The herds are listed according to size, i. e. the number of animals in the herds at fir
BPIV3 and/or BCoV out of investigated animals is shown.
The results are based on detection of antibodies in paired serum samples. Animals
titre increased ≥ 70%. The mean age is at first sampling.The mean size of the herds with co-infections was sig-
nificantly larger (p = 0.013) than for the herds with single
agent infection. In the herds with co-infections the num-
ber of BRSV positive animals dominated (Table 2).
In two of the herds (#2 and 3), the serological results
were ambiguous. In herd #2, paired serum samples were
lacking. In herd #3 the animals had an increased anti-
body response against BCoV but in addition one animal
had a increase of the level of antibodies against BRSV
and BPIV3, but below the threshold set as positive. Sam-
ples from the animals with antibody response to BRSV
or ambiguous results were analysed for detection of
BRSV with RTqPCR.
Detection of BRSV by RTqPCR
Of 95 collected nasal swabs of the 21 herds, 86 were se-
lected for analysis based on the serological results.
Forty-two (49%) of these were positive for BRSV by
RTqPCR. Of the 36 animals where both nasal swabs and
BAL samples were tested, 20 (56%) were BRSV positive
on nasal swabs and 24 (67%) on BAL samples. The dif-
ference between the results of the BAL and nasal swabsak of respiratory disease
on
led
BPIV3 infection
No. pos/sampled
BCoV infection
No. pos/sampled
Serological detection
0/5 0/5 BRSV
0/2 0/2 BRSV
0/3 0/3 BRSV
0/5 0/5 BRSV
0/5 0/5 BRSV
0/7 0/7 BRSV
0/7 0/7 BRSV
0/4 4/4 BCoV
0/5 0/5 BRSV
0/3 0/3 BRSV
0/3 1/3 BRSV/BCoV
0/6 0/6 BRSV
4/5 2/5 BRSV/BPIV3/BCoV
0/5 0/5 BRSV
0/5 1/5 BRSV/BCoV
0/5 1/5 BCoV
2/3 0/3 BPIV3
0/5 0/5 -
2/6 5/6 BRSV/BPIV3/BCoV
3/5 1/5 BRSV/BPIV3/BCoV
11/94 15/94
st sampling. The ratio of animals with acute antibody response against BRSV,
were defined as positive for infection if they seroconverted or if the antibody
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(p = 0.469). Eighteen herds were positive in TA or BAL
and nasal swabs by RTqPCR, six animals were positive
only for the BAL samples, and two animals only positive
for nasal swabs. Of the 19 TA samples analysed, eight
were RTqPCR positive. A total of 51 animals from 16
herds were RTqPCR positive for BRSV while two add-
itional herds were positive by ELISA. From the nasal
swabs sampled prior to the outbreak in herd #17, four
(4.3%) of the 93 were found positive for BRSV.
Phylogenetic analysis
Nucleotide sequences from the BRSV G protein gene
were successfully obtained from 10 herds and from the
isolate from 1976. From the additional six herds that
were positive for BRSV by RTqPCR, the virus load was
below the threshold for achievable sequencing (Table 3).
The Norwegian BRSV nucleotide sequences obtained
from 2009–2011 all belonged to subgroup II along with
other Scandinavian isolates (Figure 1). The total nucleotideTable 3 Results of RTqPCR for BRSV at herd level with
corresponding strain and sequence ID of positive herds
Herd no. BRSV
RTqPCR
Retrieved
sequence
BRSV
strain
Sequence
ID
1 - nt
2 + + B A2/N/09
3 nt nt
4 + + B A3/N/09
5 nt nt
6 + + B O1/N/09
7 + -
8 + -
9 - nt
10 + -
11 + + A O2/N/10
12 - nt
13 + + A Os1/N/10
14 + + A O3/N/10
15 + -
16 + -
17* + + B O4-4B/N/11
O4-4S/N/11
18 + + B O5/N/11
19 + + A H1/N/11
20 + + A R1/N/11
21 + nt
Total no. of pos 16 10
nt not tested. + = positive and – = negative for RTqPCR detection of virus. *ID
for the two different sequences, obtained from the broncheoalveolar lavage
and nasal swab of the same animal, are shown.difference of the gene fragment was only between 0.15%
and 0.31%. The isolate from 1976 (A1/N/76) formed a sep-
arate branch (Figure 1). The difference between A1/N/76
from the sequences from 2009–11 samples was between
4.9% and 6.2%.
The deduced amino acids from the Norwegian se-
quences separated in two distinct strains called A and B.
The occurrence of the A and B strains overlapped both
temporarily and geographically. Six nucleotides and five
amino acids systematically differed between strain A and
B (Figure 2) i.e. five of the six consistently differing nu-
cleotides gave nonsynonymous substitutions.
The G protein gene nucleotide sequences obtained from
nasal swabs and BAL samples from five of the same indi-
viduals in herd #17 were identical, apart from one nucleo-
tide difference found in one sequence obtained from a
nasal swab of one animal. This resulted in a substitution
from Threonine to Isoleucine. Apart from this single substi-
tution, samples from all animals of herd #17 were identical,
including the three sequences obtained from samples prior
to disease outbreak in herd #17.
Figures 1 and 2 are deposited in Dryad and can be
found at http://doi.org/10.5061/dryad.6k8b1.Discussion
The herds that were included in this study represented
commercial cattle farms where veterinary practitioners
had reported outbreaks of acute respiratory disease. Our
results indicated that BRSV is the dominating etiological
agent in acute outbreaks of BRD in Norway. This was
supported by both serology by ELISA and virus detec-
tion by RTqPCR.
In the majority of outbreaks BRSV was the only virus
detected. When several agents were detected in the same
herd, BRSV was always present and the number of BRSV
positive animals was higher than for BPIV3 and BCoV,
supporting the view of BRSV as the main pathogen. The
herds with two or three respiratory viruses present at
the same time were significantly larger than the others.
This indicates that the infection dynamics may be more
complex in larger herds.
The nucleotide sequences of the BRSV G protein gene
from BAL samples and nasal swabs, i.e. from lower and
upper respiratory tract, were identical for each individual
in herd #17 with the exception of one sequence that had
a single substitution of a nucleotide. Similarly, the se-
quences obtained from this herd collected before and
during the disease outbreak were also identical, indicat-
ing the dominance of a single virus strain during the
outbreak.
This herd is large with extensive purchase of livestock
from all parts of the country and is thus at a higher risk
of the introduction of different strains of virus.
Figure 1 Phylogeny of the BRSV G gene. Phylogeny showing the relationship among 31 selected nucleotide sequences based on a 472 nt
part from nucleotide number 178 to 649 of the G gene of BRSV. The sequences from this study, labelled with “*”, originated from 10 different
farms with outbreaks of respiratory disease in Norway between 2009 and 2011, and one isolate from an outbreak in 1976. Included are also
representatives of the six genetic subgroups of BRSV and recent published Swedish and Danish strains. The genetic subgroups (I-VI) and the
strain type of the Norwegian sequences (A or B) are indicated on the right. The strains are indicated by the isolate name with GenBank
Accession numbers AF188585, AF188586, AF188588, AF188604, JN619431, JN619439, JN619446, L27802, M58307, Y08717, Y08718, U92098,
U92102, U92103, U24714-U24716, U33539 and U57823. The GenBank accession numbers of the Norwegian strains are: KF501149-KF501155,
KF501159, KF501160 and KF501170-KF501172. The bootstrap values are shown next to the branches. The trees are drawn to scale, with branch
lengths measured in the number of substitutions per site.
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but it is the part where most variation has been found
[17,26]. This indicated that during a disease outbreak a
virus with identical G genes dominates within a herd or an
animal, suggesting that BRSV outbreaks are initiated by
virus of apparently high fitness. This is in accordance with
previous findings of Larsen et al. [27] that revealed that
cell-culture adaption and passages in cells and/or calves did
not induce extensive changes in the G protein gene. Whenthe PCR products were generated for sequencing in the
present study, a proof-reading polymerase was used to min-
imise procedure generated mutations. The sequences were
obtained directly from PCR products and thus mirror the
consensus base at each position, i.e. the dominating se-
quence. However, low abundant sequence variants would
not have been detected by this procedure.
There was no statistical significant difference in the
RTqPCR results of the BAL or nasal swabs from the
Figure 2 Amino acid sequences 60 to 215 of the G protein gene of BRSV isolates. Comparison of deduced amino acid sequences.
Designations on the left indicate the isolate ID. The GenBank accession number of the Lelystad strain is U33539.
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from a limited number of animals they indicate that
nasal swabs as samples for RTqPCR testing can be use-
ful. This is important knowledge for the collection of
samples from the field, as the nasal swabs are much
more convenient to collect than BAL.
All the BRSV G protein sequences obtained in this
study, including the A1/N/76 isolate, belonged to genetic
subgroup II along with the other most recent North
European isolates [17]. The deduced amino acid se-
quences retrieved in our study could be divided into two
clades where six nucleotide substitutions systematically
gave a difference of five amino acids between the clades.
Prozzi et al. [28] showed that the antigenic subgroups
are related to the sequence variability of the central
conserved region (codon position 154 to 192) of the
G protein. In another study, Langedijk et al. [29] demon-
strated that two point mutations at positions 180 and
205 defined the classification of the antigenic subgroups.
Some of the differences observed in the present study
were located in the area that is determinative for antigen
subgrouping [29] as well as in the conserved central
hydrophobic region [17]. Amino acid residue 205 of the
Norwegian strain B is a Pro, while for strain A and the
other aligned isolates Ala is present. Proline can impede
the protein folding and thus potentially modify proper-
ties of the G protein. In the study of the evolution of
BRSV by Valarcher et al. [17], Ala205 was found for sub-
groups I and II while Thr205 was present for the other
subgroups. It was speculated whether this could intro-
duce an O-glycosylation site that could modify the anti-
genicity of the linear epitope described for positions 199
to 209 [29]. Furthermore the Ala205 to Thr205 substitu-
tion caused lack of binding of a specific MAb used for
antigenic subgrouping of BRSV [29]. This illustrates the
central role of residue 205 and could indicate that the
Ala205 to Pro205 mutation found in our material could
be a factor that would ease the similar spatiotemporal
circulation of both strains. It is interesting that the two
distinct strains were not found within the same herd. A
recent Swedish study with samples from different parts
of Sweden showed that the viral G protein sequences
were highly similar [30] and could not be divided into
distinct strains while in Denmark extensive sequence di-
vergence (11%) of the G protein gene was found in re-
current outbreaks in closed herds [19].
Based on the phylogenetic analysis, the Norwegian
BRSV strains showed the highest degree of homology
with recently published Swedish [30] and Danish strains
[19], supporting the theory of a geographical and tem-
poral clustering. The A1/N/76 isolate from 1976 formed
a separate branch in subgroup II, clearly different from
the current Scandinavian sequences. The distant relation
between this isolate and the current Norwegian strainsdo not indicate if the current strains are direct descen-
dants, or if they only originate from a common ancestor.
This isolate, causing a large outbreak of BRSV in
Norway at that time, was originally thought to be intro-
duced to Norway by an animal imported from Denmark
[12]. Further studies, including samples from the time
period between these isolates, are needed to determine
the origin of the current strains.
Conclusions
The present study shows that BRSV is currently the
most important etiological agent in epidemics of respira-
tory disease in cattle in Norway, and that it often acts as
the only viral agent. The current Norwegian strains of
BRSV belong to the genetic subgroup II along with other
North European isolates, supporting the theory of geo-
graphical and temporal clustering of BRSV. The cur-
rently circulating BRSV could be divided into two strains
that were present in the same geographical area at the
same time.
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